| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Mark D. Gorrell | Q38799589 |
| Catherine Anne Abbott | Q39188539 | ||
| W. Bret Church | Q59310179 | ||
| P2093 | author name string | D Yu | |
| G A Bishop | |||
| N A Shackel | |||
| G W McCaughan | |||
| M T Levy | |||
| D G Bowen | |||
| A F Sharland | |||
| J Napoli | |||
| P H McGuinness | |||
| L Slaitini | |||
| P921 | main subject | inflammation | Q101991 |
| liver cirrhosis | Q147778 | ||
| pathogenesis | Q372016 | ||
| P304 | page(s) | 172-191 | |
| P577 | publication date | 2000-04-01 | |
| P1433 | published in | Immunological Reviews | Q15724582 |
| P1476 | title | Molecular pathogenesis of liver disease: an approach to hepatic inflammation, cirrhosis and liver transplant tolerance | |
| P478 | volume | 174 |
| Q37197025 | A Possible Role for TNF-α in Coordinating Inflammation and Angiogenesis in Chronic Liver Disease and Hepatocellular Carcinoma |
| Q33770974 | Aging mesenchymal stem cells fail to protect because of impaired migration and antiinflammatory response |
| Q44651565 | Alterations in the expression and modification of histonesin the liver after injury |
| Q33715938 | Application of microRNA and mRNA expression profiling on prognostic biomarker discovery for hepatocellular carcinoma |
| Q44302883 | Association of CD8 T cells with depression and anxiety in patients with liver cirrhosis |
| Q37043515 | Bioconjugation of oligonucleotides for treating liver fibrosis |
| Q33760729 | Cell adhesion on polyelectrolyte multilayer coated polydimethylsiloxane surfaces with varying topographies. |
| Q34056271 | Chemokines in the immunopathogenesis of hepatitis C infection |
| Q24298613 | Cloning and characterization of dipeptidyl peptidase 10, a new member of an emerging subgroup of serine proteases |
| Q24290340 | Cloning, expression and chromosomal localization of a novel human dipeptidyl peptidase (DPP) IV homolog, DPP8 |
| Q39275991 | Cytokine profiles and hepatic injury in occult hepatitis C versus chronic hepatitis C virus infection |
| Q35001014 | Developing strategies for liver fibrosis treatment |
| Q36783164 | Dipeptidyl peptidase-4: a key player in chronic liver disease |
| Q35189265 | Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV. |
| Q43218274 | Dipeptidylpeptidase--IV, a key enzyme for the degradation of incretins and neuropeptides: activity and expression in the liver of lean and obese rats |
| Q35185501 | Distinct cellular responses differentiating alcohol- and hepatitis C virus-induced liver cirrhosis. |
| Q44701378 | Expression of cytokines (TNF-alpha, IL-1alpha, and IL-2) in chronic hepatitis C: comparative hybridocytochemical and immunocytochemical study in children and adult patients |
| Q35666213 | Fibrosis progression in chronic hepatitis C virus infection |
| Q51566491 | Haematological and immunological adaptations of non-pregnant, non-lactating dairy cows to a high-energetic diet containing mycotoxins. |
| Q43918476 | Hepatic covalent adduct formation with zomepirac in the CD26-deficient mouse |
| Q35365390 | Identification of novel molecules and pathogenic pathways in primary biliary cirrhosis: cDNA array analysis of intrahepatic differential gene expression |
| Q41893446 | Inhibitory effect of Huangqi Zhechong decoction on liver fibrosis in rat. |
| Q27478238 | Insights into the Pathobiology of Hepatitis C Virus-Associated Cirrhosis |
| Q28218916 | Intrahepatic expression of the hepatic stellate cell marker fibroblast activation protein correlates with the degree of fibrosis in hepatitis C virus infection |
| Q37134499 | MicroRNA-146a-5p Negatively Regulates Pro-Inflammatory Cytokine Secretion and Cell Activation in Lipopolysaccharide Stimulated Human Hepatic Stellate Cells through Inhibition of Toll-Like Receptor 4 Signaling Pathways |
| Q33232512 | Morphological and serum hyaluronic acid, laminin and type IV collagen changes in dimethylnitrosamine-induced hepatic fibrosis of rats |
| Q91863504 | Physiologically based pharmacokinetic model of the DPP-4 inhibitor linagliptin to describe its nonlinear pharmacokinetics in humans |
| Q34062829 | Pleiotropic effects of the dipeptidylpeptidase-4 inhibitors on the cardiovascular system |
| Q39377477 | Potential disease biomarkers: dipeptidyl peptidase 4 and fibroblast activation protein. |
| Q35113393 | Potential of soluble CD26 as a serum marker for colorectal cancer detection. |
| Q44427189 | Similar increased serum dipeptidyl peptidase IV activity in chronic hepatitis C and other viral infections. |
| Q34546455 | Spontaneous acceptance of liver transplants in rodents: evidence that liver leucocytes induce recipient T-cell death by neglect |
| Q36209805 | Synthesis of endotoxin receptor CD14 protein in Kupffer cells and its role in alcohol-induced liver disease |
| Q28533607 | Tacrolimus (FK506) prevents early stages of ethanol induced hepatic fibrosis by targeting LARP6 dependent mechanism of collagen synthesis |
| Q40680112 | The coming impact of gene expression profiling on the diagnosis and treatment of HCV-associated liver disease |
| Q36647336 | The hepatic transcriptome in human liver disease |
| Q44507589 | The pharmacokinetic and biological activity profile of dexamethasone targeted to sinusoidal endothelial and Kupffer cells |
| Q33906565 | The role of chemokines in the recruitment of lymphocytes to the liver |
| Q36320026 | Tolerance induction by viral in vivo gene transfer |
Search more.